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Reduction of Sample Heterogeneity through Use of Population
Substructure: An Example from a Population of African American
Families with Sarcoidosis
Cheryl L. Thompson, Benjamin A. Rybicki, Michael C. Iannuzzi, Robert C. Elston,
Sudha K. Iyengar, Courtney Gray-McGuire, and the Sarcoidosis Genetic Analysis Consortium (SAGA)
Sarcoidosis is a granulomatous inﬂammatory disorder of complex etiology with signiﬁcant linkage to chromosome 5,
and marginal linkage was observed to ﬁve other chromosomes in African Americans (AAs) in our previously published
genome scan. Because genetic factors underlying complex disease are often population speciﬁc, genetic analysis of samples
with diverse ancestry (i.e., ethnic confounding) can lead to loss of power. Ethnic confounding is often addressed by
stratifying on self-reported race, a controversial and less-than-perfect construct. Here, we propose linkage analysis stratiﬁed
by genetically determined ancestry as an alternative approach for reducing ethnic confounding. Using data from the
380 microsatellite markers genotyped in the aforementioned genome scan, we clustered AA families into subpopulations
on the basis of ancestry similarity. Evidence of two genetically distinct groups was found: subpopulation one (S1) com-
prised 219 of the 229 families, subpopulation two (S2) consisted of six families (the remaining four families were a
mixture). Stratiﬁed linkage results suggest that only the S1 families contributed to previously identiﬁed linkage signals
at 1p22, 3p21-14, 11p15, and 17q21 and that only the S2 families contributed to those found at 5p15-13 and 20q13.
Signals on 2p25, 5q11, 5q35, and 9q34 remained signiﬁcant in both subpopulations, and evidence of a new susceptibility
locus at 2q37 was found in S2. These results demonstrate the usefulness of stratifying on genetically determined ancestry,
to create genetically homogeneous subsets—more reliable and less controversial than race-stratiﬁed subsets—in which
to identify genetic factors. Our ﬁndings support the presence of sarcoidosis-susceptibility genes in regions identiﬁed
elsewhere but indicate that these genes are likely to be ancestry speciﬁc.
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Heterogeneity has been cited as a source of many difﬁ-
culties facing genetic studies of complex disease today.1
The source of heterogeneity may include ambiguous or
imprecise deﬁnition of the trait of interest (phenotypic
heterogeneity),2 more than one locus being involved in
the disease expression (locus heterogeneity),3 more than
one variant at the same locus contributing to disease (al-
lelic heterogeneity),4 or multiple population-speciﬁc loci
or alleles predisposing to disease represented in the same
sample (sample heterogeneity).5–8 When sample hetero-
geneity or ethnic confounding is suspected, it is common
to stratify a collection of pedigrees by self-reported race
before conducting genetic analysis. Although race is a rea-
sonable surrogate for genetic similarity when nothing else
is available,9–13 race does not always accurately reﬂect pop-
ulation of origin or genetic makeup,14–16 particularly in
heterogeneous admixed groups. It is known that African
Americans (AAs), for example, are admixed with European
Americans (EAs) and other populations to varyingdegrees,
as illustrated by Parra et al.,17 who showed that AAs sam-
pled from different geographic regions show different
amounts of European admixture, from 6.8% in a Jamaican
sample to 22.5% in a sample from New Orleans. Addi-
tionally, because race is a social construct, it can be con-
troversial18–23 and, some would argue, should not be used
in genetic studies.
In the United States, sarcoidosis (MIM 181000), a mul-
tisystem inﬂammatory disorder that tends to cluster in
families, has both a higher incidence and greater severity
in AAs than in EAs.24,25 In a U.S. population–based study,
the incidence rate was estimated at 12.1 per 100,000 for
EA females, 9.6 per 100,000 for EAmales, 39.1 per 100,000
for AA females, and 29.8 per 100,000 for AA males.26
A clinically heterogeneous disease, sarcoidosis most fre-
quently affects the lungs but also commonly affects the
liver, eye, skin, and lymph nodes and has variable degrees
of population-speciﬁc severity.27 For example, cardiac in-
volvement in sarcoidosis is more common among Japa-
nese,28 and acute sarcoidosis is more common among Scan-
dinavians,29 whereas chronic sarcoidosis is more common
among AAs.27,30 Although the risk factors for sarcoidosis
are unknown, studies indicate that genetic components
are likely to play an important role,31,32 and disparities in
prevalence and severity between populations havenot been
www.ajhg.org The American Journal of Human Genetics Volume 79 October 2006 607
explained solely by differing environments. Signiﬁcant
linkage evidence from genome scans of a European sam-
ple33 and the AA sample34 used here support both the pres-
ence and the population speciﬁcity of a genetic compo-
nent to sarcoidosis.
In the present study, we propose stratifying by ances-
try similarity estimated from highly polymorphic genetic
markers—instead of self-reported race—as a means of re-
ducing sample heterogeneity. We show, in an AA sample
ascertained for sarcoidosis, strong evidence of population-




The study sample from SAGA consists of 519 full- and half-sibling
pairs in 229 AA nuclear families, each with at least two affected
offspring. The details of the study population—including diag-
nostic criteria for affected siblings, screening criteria of unaffected
siblings to exclude undiagnosed sarcoidosis, and other exclusion
criteria—are published elsewhere.32,35 Informed consent was ob-
tained from all subjects, and the institutional review boards at
all participating locations approved the research.
Cluster Analysis
Percentage of inclusion in clusters with similar genetic ancestry
was estimated using the program STRUCTURE.36 STRUCTURE im-
plements an algorithm that deﬁnes and places individuals into
K clusters on the basis of subpopulation-speciﬁc allele frequen-
cies. K is deﬁned in advance but can be varied to ﬁnd the value
of K that provides the most parsimonious ﬁt to the data. The
admixture model in STRUCTURE estimates percentage of inclu-
sion in each cluster. For this analysis, STRUCTURE was run using
the linkage model,37 which provides an extension to the admix-
ture model to allow for correlations between nearby markers.
Tested models included those assuming both two and three un-
derlying subpopulations ( and , respectively), but,Kp 2 Kp 3
since the family cluster conﬁgurations did not change with K,we
report only the results from the more parsimonious (two-sub-
population) model.
A Marshﬁeld screening set of 380 microsatellite markers from
the original genome scan was used for the analysis. This marker
set provided reasonable coverage of the genome, yet, with an
average spacing of 9 cM, markers were not so closely spaced that
they were too highly correlated for an analysis of population
structure.37 These markers were not chosen for their ancestral
informativity; rather, they were the data available from the ge-
nome scan. However, Darvasi and Shifman38 suggest that the
Marshﬁeld screening set contains more than enough ancestral
informativity to be sufﬁcient for admixture analysis, which is
even more sensitive to marker informativity than is the clustering
analysis performed here.
Clusters were deﬁned as consisting of families in which at least
94% of each individual’s genome appeared to derive from a com-
mon population. Our choice of 94% as the cutoff for deﬁning
the subpopulations was based on values calculated from the data,
as detailed in the “Results” section. Because we used all members
of the family in the analysis, we violated the assumption in
STRUCTURE that all individuals are independent. Although vio-
lation of this assumption has not been thoroughly investigated,
the created bias would affect the estimates of ancestry uniformly
across the sample but still allow for accurate clustering of the
families, which was our primary goal.
Stratiﬁed Linkage Analysis
Multipoint identity-by-descent (IBD) sharing estimates for full-
and half-sibling pairs were obtained using GENIBD (S.A.G.E.).
Model-free linkage analysis was performed using the Haseman-
Elston regression, as implemented in SIBPAL (S.A.G.E.). The orig-
inal Haseman-Elston method regresses the squared sib-pair trait
difference on the estimated IBD sharing between siblings.39 We
chose to use the original Haseman-Elston, instead of the revised40
or weighted Haseman-Elston,41 because it is more robust for a
small number of concordantly unaffected sibling pairs, as was the
case in one of the subpopulations. Therefore, the results shown
here for the full sample are slightly different from those in the
original report.34 The binary trait of interest was the presence or
absence of medically documented sarcoidosis. Since the current
implementation of SIBPAL allows only for full siblings—and our
sample contained 101 half-sibling pairs—we included a covariate
indicative of half-sibling status, as was done in the original ge-
nome scan.32 In regions where the nominal P value was !.01, we
calculated empirical P values from the full siblings alone, for
whom a valid permutation test is available.
Because multiple analyses of the same data can result in in-
creased type I error, we performed a test of interaction between
subpopulation membership and allele sharing to conﬁrm the dif-
ference in results from the full and stratiﬁed samples.42 To do this,
we ﬁtted two regression models: (1) a reduced model, in which
the sibling trait difference was regressed on an intercept, the es-
timated allele sharing at the marker of interest, and an indicator
variable for subpopulation effect and (2) a full model, which in-
cluded the reduced model plus an allele sharing by subpopula-
tion-interaction term. The difference in the residual sumsof squares
for the reduced and full models divided by twice the mean square
error for the full model could then be compared with an F dis-
tribution with degrees of freedom in the numerator equal to the
number of subpopulations (2) and the degrees of freedom in the
denominator equal to the difference in the number of siblings
and the number of sibships (227).
Analysis of Differences between Subpopulations
We evaluated the difference in the proportion of affected family
members in each subpopulation who showed involvement of
ocular, bone/marrow, liver, lymph, and skin organ systems. Or-
gan-system involvement was obtained through a standardized
review of each affected individual’s medical records. Our test was
based on the test for a difference between two sample propor-
tions, for which the test statistic is given as:
ˆ ˆ(p  p ) (p  p )1 2 1 2 0zp .
j ˆ ˆ(p p )1 2
In this formulation, is the difference in proportions(p  p )1 2 0
under the null hypothesis, which, in this case, equals 0, and
is the SD of the difference in sample proportions. This testj ˆ ˆ(p p )1 2
statistic (z) can then be compared with a standard normal
distribution.43
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No. of sibships 219 6
Mean sibship size 2.44 4.67
No. of all sib pairs 454 54
No. (%) of half-sib pairs 111 (24.4) 5 (9.3)
No. (%) of concordant unaffected sib pairs 15 (3.3) 2 (3.7)
No. (%) of concordant affected sib pairs 298 (65.6) 27 (50.0)
No. (%) of discordant sib pairs 141 (31.1) 25 (46.3)
No. (%) of sibships with size 4 24 (11.0) 5 (83.3)
To compare the severity of the pulmonary phenotypes in those
individuals affected with sarcoidosis, we used three measures—
radiographic resolution, percentage of predicted forced vital ca-
pacity (FVC) at follow-up, and a pulmonary-severity score with
a range from 1 (least severe) to 6 (most severe) based on radio-
graphic staging of disease and pulmonary function. The differ-
ence in the percentage of each population with radiographic res-
olution was evaluated using the above test of difference in pro-
portions. Average values of percentage of predicted FVC and se-
verity score were compared between the two subpopulationswith
use of a standard t test.
Results
Cluster Analysis
Two genetically distinct subpopulations of families were
found, via STRUCTURE, in our AA collection. A majority
of the sample, 547 individuals in 219 families (454 sibling
pairs), clustered together, and each derived 194% (average
99.4% [range 94.7%–99.9%]) of its genome from the same
ancestry. We will refer to this group as “subpopulation
one” (S1). Twenty-eight individuals in six families (54
sibling pairs) clustered with 199% (average 99.9% [range
99.7%–99.9%]) of their ancestry deriving from a unique
subpopulation, henceforth called “subpopulation two”
(S2). Individuals in the four remaining families were es-
timated to share an average of 80.1% (range 72.7%–86.8%)
of their ancestry from S1 and 19.9% (range 13.2%–27.3%)
of their ancestry from S2. Because of the high level of
genetic heterogeneity within these families, they were ex-
cluded from further analysis. The pedigrees in S2 tended
to be larger and also to have a higher proportion of dis-
cordant sibling pairs compared with the pedigrees in S1
(table 1). To verify that this difference in mean family size
was not the source of the observed substructure, we reran
STRUCTURE after randomly removing siblings from the
larger sibships, such that no sibship size was 13. This re-
sulted in only a slight change, with two of the original
six S2 families no longer clustering in that group. This
suggests that, although family size may have inﬂuenced
the clustering, the sibship size was not sufﬁcient to explain
the subdivisions—even though 24 of the S1 families also
had a sibship size 13—since all of the S1 families remained
clustered together.
We also reran STRUCTURE after removing those mark-
ers shown, a priori, to be linked to sarcoidosis ( inP ! .01
the original scan), so that our family clustering was not
driven by similarities in linked regions. Only one family
no longer obviously belonged to S1 and one no longer
obviously belonged to S2, indicating that, although link-
age to disease may play a role in clustering, it, like family
size, is unlikely to bias our results.
Stratiﬁed Linkage Analysis
The results of the stratiﬁed linkage analyses of S1 and S2,
together with the results from the original genome scan
including all families, are shown in ﬁgure 1. The stratiﬁed
analysis suggests that the marginal signiﬁcance ( )Pp .05
of several of the regions identiﬁed in the original scan is
due only to S1 (1p22, 11p15, and 17q21) or S2 (5p15-13
and 20q13) families, whereas other regions remain signif-
icant ( ) in both subpopulations (2p25, 3p24, 5q11,P .05
5q35, and 9q34). Evidence of two new sarcoidosis suscep-
tibility loci with linkage only in the S2 families (2q37 and
3p21-14) was also found.
Several of the signals originally identiﬁed in the genome
scan at a signiﬁcance level of are now signiﬁcantPp .05
at in one or more subpopulation, despite smallerPp .01
sample sizes (table 2). In some cases (for 3p21-14, 5p15-
13, 17q21, and 20q13), this increase in signiﬁcance was
several orders of magnitude. The peak on 17q21 was not
even highlighted in the original scan,34 because the sig-
niﬁcance was only marginal. In 4 of 12 cases, the differ-
ence in the effects between the combined and stratiﬁed
samples was signiﬁcantly different at (table 2),ap .05
further demonstrating the gain of reducing sample het-
erogeneity in this way. These pronounced linkage signals
are likely unique to the stratum being analyzed, since the
reduced sample size of the stratumwould lower the power
to detect the effect size that was observed in the full sample.
Empirical P valueswere calculated for those regions show-
ing a nominal P value !.01. These values were quite similar
to the asymptotic P values; therefore, only the asymptotic
P values are reported.
To assess these ﬁndings further, we looked at the mean
allele sharing (p) between concordant and discordant sib-
ling pairs at the peaks showing a P value of !.01 (TPO,
D3S1285, D5S817, D5S2500, and D20S480 in S2; D5S2500
and D17S2180 in S1). Since the mean allele sharing for
the discordant sibling pairs at all these peaks remains sig-
niﬁcantly !0.5 ( in all cases) and is thus less thanP ! .02
is expected under the null hypothesis, these are not likely
to be false-positive results. The peaks at TPO, D3S1285,
and D5S817 in S2 appear to be driven primarily by sharing
between concordantly affected sibling pairs, since themean
allele sharing in the concordantly affected sibling pairs is
much 10.5 (10.6 in all cases). At D5S2500 in S2, the signal
appears to be driven by the decreased sharing among dis-
cordant pairs; the sharing for the concordant pairs was only
slightly 10.5, but the sharing between discordant pairs was
estimated to be only 0.2994. The peaks at D5S2500 and
D17S2180 in S1 show mean allele sharing much 10.5 in
concordantly unaffected sibling pairs (0.6). The peak in
Figure 1. Results of stratiﬁed linkage analysis. In each plot, the solid line represents the results from the original (full sample) linkage analysis, plotted as the log(P value)
versus the distance from the ﬁrst marker. The dashed line represents the results from S1. The dotted line represents the results from S2. The horizontal lines represent P values of
(lower) and (upper). The values to the right of the plots represent the corresponding LOD scores.3 51.0# 10 2.2# 10
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Table 2. Peak P Values by Subpopulation
Region Marker
P for
Full Sample S1 S2 Differencea
1p22 D1S551 .056 .036 .20 .49
2p25 TPO 34.64# 10 .026 33.10# 10 .06
2q37 D2S1363 .134 .272 .034 .31
3p24 D3S3038 .043 .043 .057 .22
3p21-14 D3S1285 .178 .639 44.58# 10 41.44# 10
5p15-13 D5S817 .019 .225 54.18# 10 44.52# 10
5q11 D5S2500 45.00# 10 .010 34.68# 10 .10
5q35 D5S1456 .052 .023 .112 .45
9q34 D9S1825 36.26# 10 .044 .024 33.19# 10
11p15 D11S1984 38.86# 10 .038 .329 .96
17q21 D17S2180 .014 39.22# 10 .856 .42
20q13 D20S480 .010 .054 54.71# 10 31.96# 10
a For an F test of signiﬁcant interaction between allele-sharing and subpopulation
membership.
S2 on chromosome 20 (D20S480) shows mean allele shar-
ing in both concordantly affected sibling pairs and con-
cordantly unaffected sibling pairs 10.5 (10.62 in bothcases).
Phenotypic Differences between Subpopulations
Evaluation of phenotypic differences showed that the af-
fected individuals in the families of S2 had more ocular
involvement and that the affectedmembers of the S1 fam-
ilies had more liver and lymph involvement; patients in
the S2 families also had a lower percentage of predicted
FVC at diagnosis but a higher percentage of predicted FVC
at follow-up (table 3). However, only the difference in liver
involvement and FVC at follow-up were statistically sig-
niﬁcant at the .05 level, indicating that the linkage results
seen here are due to subpopulation, not phenotypic dif-
ferences. To further assess this, we compared the linkage
peaks from this study with those found for liver and FVC
at follow-up in a subphenotype-speciﬁc analysis (authors’
unpublished data). We found only slight overlap, support-
ing our previous assertion of subpopulation—not pheno-
typic—differences.
Discussion
Heterogeneity has been blamed for lack of replication, dif-
ﬁculty in ﬁne mapping, and other challenges present in
genetic studies of complex human diseases. Although strat-
egies to address heterogeneity in linkage analysis have
been developed, most were not feasible for this data set.
Falk,44 for example, showed that including a heterogeneity
parameter into model-based linkage methods allowed a
more accurate estimate of the recombination fraction.How-
ever, model-free linkage methods are considered more ap-
propriate for studies of complex diseases in which the un-
derlying genetic model is unknown, as was the case here.
Themodel-free two-level Haseman-Elston45 test can be used
to model heterogeneity but requires the estimation of
additional parameters—which requires increased sample
size—and does not ultimately identify for follow-up of
those families most likely to be linked to that region. Strat-
iﬁcation by race, a simple alternative, was not feasible in
our sample, because all participants reported that they
belong to the same race. We therefore applied genetic an-
cestry estimated from the genome-scan data, to reduce
sample heterogeneity.
Our approach was not without certain assumptions and
restrictions. Ancestrally informativemarkerswere not avail-
able for this analysis. In theory, such markers would have
improved our ability to cluster families into appropriate
subpopulations. However, theMarshﬁeld screening set has
been shown to be sufﬁciently informative for admixture
analysis,38 a method much more contingent on ancestry
informativity than the methods used here, and, in our
case, it was a readily available data set. We also chose to
use all members of the families, not just a single individ-
ual, violating the assumption of independence in STRUC-
TURE. For the reasonsmentioned above, however, the bias
created by this violation did not greatly affect the clus-
tering of the families, which was our primary goal. We
also recognize that S2 was a small sample of only six fam-
ilies (54 sib pairs), but empirical and asymptotic P values
for all regions of interest were in close agreement. Finally,
we recognize that use of the same families to generate the
clusters as those used in assessing linkagemight cause bias,
since similarities in clusters could be driven by similarities
in the linked regions of the genomes of the affected in-
dividuals. However, because we included unaffected indi-
viduals and conducted a whole-genome scan (not an ex-
amination of only selected candidate genes), we think this
potential bias is minimal. Additionally, the results of the
clustering after removal of the linked markers shows that
the linked markers only minimally affected the clustering.
Despite these limitations, by stratifying our self-reported
racially homogeneous sample on the basis of genetically
determined common ancestry, our ability to detect linkage
was strengthened.We identiﬁed a novel linkage signal and
an increase in the signiﬁcance of several previously iden-
tiﬁed signals. Certainly, one can argue that stratiﬁcation
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Table 3. Phenotypic Differences among Affected Persons by
Subpopulation
Phenotype S1 S2 Pa
No. affected:unaffected (% unaffected) 485:62 (11) 20:8 (29)
Pulmonary related:
Percentage of radiographic resolution 25.0 15.8 .82
Percentage of predicted FVC at follow-up 86.4 95.7 .04
Severity scoreb (average) 2.81 2.65 .34
Extrathoracic organ involvement (%):
Ocular 34.7 52.9 .06
Bone/marrow 7.0 5.9 .43
Liver 22.2 0 !.001
Lymph 27.2 11.8 .08
Skin 42.6 31.6 .17
a P value of test of differences between subpopulations.
b Score of 1–6; results are based on follow-up chest x-ray and percentage of
predicted FVC.
of a sample, even random stratiﬁcation, could result in
increased signiﬁcance for linkage in some locations. How-
ever, one would not expect, by chance alone, that 10 of
the 11 signals found in the stratum would be in the same
location as those previously identiﬁed.
Finally, the results of this study highlight the limitation
of using race as a classiﬁcation tool for genetic studies.
Some view race as a social construct, with little genetic
relevance, that can potentially lead to discrimination and
should be avoided (reviewed by the Race, Ethnicity, and
GeneticsWorking Group46). Others contend that self-iden-
tiﬁed race is highly correlated with ethnicity,12 so that
when no other data are available, it is a reasonable sur-
rogate, but it may not always be accurate or practical. For
example, 39.6% of AAs did not know all of their biological
grandparents and therefore could not classify them by an-
cestry.14 Similarly, individuals within a family of mixed
race often classiﬁed themselves as belonging to only one.47
Lastly, as demonstrated here and reported by others,48 a
study sample drawn from a single self-reported race may
contain several subpopulations that are genetically unique
(for example, South African vs. West African in an AA
sample or Scandinavian vs. Mediterranean in a European
American sample) or that vary in degree of admixturewith
other populations. Although we are not suggesting that
this type of stratiﬁed analysis can provide greater inference
about linkage in all samples, particularly those that are
not admixed, when the ancestral populations are known
to be extremely diverse, as is the case for Africans,49 we
have shown that addressing genetic substructure is both
a feasible and a useful exercise. Although we do not assert
that this type of analysis will eliminate all discrepancies
in linkage results—nor are we able, at this stage, to deﬁn-
itively attribute our differing results to population sub-
structure—this type of analysis shows great promise for
the reduction of random variability in samples in which
genetic heterogeneity due to population substructure is
suspected.
In conclusion, this study suggests that genetic clustering
via methods such as that implemented in STRUCTURE can
effectively create genetically homogeneous subpopulations
for a linkage analysis. Our results support the presence
of population-speciﬁc sarcoidosis genes on chromosomes
1p22, 3p21-14, 5p15-13, 11p15, 17q21, and 20q13 and
suggest a previously unknown sarcoidosis-susceptibility
locus at 2q37. Studies to better classify S1 and S2 families
by population of ancestry (such as African, EA, American
Indian, Latino, etc.), as well as admixture-mapping anal-
yses, are currently under way to further elucidate genes
for sarcoidosis in AAs.
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